148 related articles for article (PubMed ID: 27150339)
1. Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment.
Del Genio G; Gagner M; Limongelli P; Tolone S; Pournaras D; le Roux CW; Brusciano L; Licia Mozzillo A; Del Genio F; Docimo L
Surg Obes Relat Dis; 2016 May; 12(4):815-821. PubMed ID: 27150339
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in glucose homeostasis and incretin hormone response at 1 and 6 months after laparoscopic sleeve gastrectomy.
Mallipedhi A; Prior SL; Barry JD; Caplin S; Baxter JN; Stephens JW
Surg Obes Relat Dis; 2014; 10(5):860-9. PubMed ID: 25002324
[TBL] [Abstract][Full Text] [Related]
3. Bariatric surgery versus conventional medical therapy for type 2 diabetes.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Leccesi L; Nanni G; Pomp A; Castagneto M; Ghirlanda G; Rubino F
N Engl J Med; 2012 Apr; 366(17):1577-85. PubMed ID: 22449317
[TBL] [Abstract][Full Text] [Related]
4. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.
Seki Y; Kasama K; Haruta H; Watanabe A; Yokoyama R; Porciuncula JP; Umezawa A; Kurokawa Y
Obes Surg; 2017 Mar; 27(3):795-801. PubMed ID: 27644433
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Diabetes Mellitus, Cardiovascular Diseases, and Cancer in Patients Undergoing Malabsorptive Surgery (Biliopancreatic Diversion and Biliointestinal Bypass) vs Medical Treatment.
Pontiroli AE; Ceriani V; Sarro G; Micheletto G; Giovanelli A; Zakaria AS; Fanchini M; Osio C; Nosari I; Veronelli AM; Folli F;
Obes Surg; 2019 Mar; 29(3):935-942. PubMed ID: 30448983
[TBL] [Abstract][Full Text] [Related]
6. A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network.
Pontiroli AE; Zakaria AS; Micheletto G; Osio C; Saibene A; Folli F;
Acta Diabetol; 2019 Feb; 56(2):163-169. PubMed ID: 30411157
[TBL] [Abstract][Full Text] [Related]
7. Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity
Borgeraas H; Hjelmesæth J; Birkeland KI; Fatima F; Grimnes JO; Gulseth HL; Halvorsen E; Hertel JK; Hillestad TOW; Johnson LK; Karlsen TI; Kolotkin RL; Kvan NP; Lindberg M; Lorentzen J; Nordstrand N; Sandbu R; Seeberg KA; Seip B; Svanevik M; Valderhaug TG; Hofsø D
BMJ Open; 2019 Jun; 9(6):e024573. PubMed ID: 31167860
[TBL] [Abstract][Full Text] [Related]
8. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol.
Murphy R; Evennett NJ; Clarke MG; Robinson SJ; Humphreys L; Jones B; Kim DD; Cutfield R; Plank LD; Hammodat H; Booth MW
BMJ Open; 2016 Jul; 6(7):e011416. PubMed ID: 27377635
[TBL] [Abstract][Full Text] [Related]
9. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms.
Astiarraga B; Gastaldelli A; Muscelli E; Baldi S; Camastra S; Mari A; Papadia F; Camerini G; Adami G; Scopinaro N; Ferrannini E
J Clin Endocrinol Metab; 2013 Jul; 98(7):2765-73. PubMed ID: 23666972
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients.
Scopinaro N; Camerini G; Papadia F; Andraghetti G; Cordera R; Adami GF
Surg Obes Relat Dis; 2016 May; 12(4):822-827. PubMed ID: 26947789
[TBL] [Abstract][Full Text] [Related]
11. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.
Ramos-Levi A; Sanchez-Pernaute A; Matia P; Cabrerizo L; Barabash A; Hernandez C; Calle-Pascual A; Torres A; Rubio M
Obes Surg; 2013 Oct; 23(10):1520-6. PubMed ID: 23702908
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.
Robert M; Ferrand-Gaillard C; Disse E; Espalieu P; Simon C; Laville M; Gouillat C; Thivolet C
Obes Surg; 2013 Jun; 23(6):770-5. PubMed ID: 23355293
[TBL] [Abstract][Full Text] [Related]
14. Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.
Thomas F; Smith GC; Lu J; Babor R; Booth M; Beban G; Chase JG; Murphy R
Obes Surg; 2016 Aug; 26(8):1924-31. PubMed ID: 26729277
[TBL] [Abstract][Full Text] [Related]
15. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery.
Ramos-Levi AM; Sanchez-Pernaute A; Cabrerizo L; Matia P; Barabash A; Hernandez C; Calle-Pascual AL; Torres AJ; Rubio MA
Obes Surg; 2013 Dec; 23(12):2020-5. PubMed ID: 23893315
[TBL] [Abstract][Full Text] [Related]
16. Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes.
Ghio B; Jiménez A; Corcelles R; Flores L; Lacy A; Vidal J
Surg Obes Relat Dis; 2017 Dec; 13(12):2004-2009. PubMed ID: 28259559
[TBL] [Abstract][Full Text] [Related]
17. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
[TBL] [Abstract][Full Text] [Related]
18. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
Malin SK; Samat A; Wolski K; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065
[TBL] [Abstract][Full Text] [Related]
19. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
[TBL] [Abstract][Full Text] [Related]
20. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
